The Orissa Minerals Development Company Limited
The Orissa Minerals Development Company Limited (ORISSAMINE.NS) Stock Competitors & Peer Comparison
See (ORISSAMINE.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial Materials Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ORISSAMINE.NS | ₹3,701.20 | -1.27% | 22.2B | -82.97 | -₹44.61 | N/A |
| VEDL.NS | ₹752.55 | +0.99% | 2.9T | 20.91 | ₹35.99 | +4.52% |
| VEDL.BO | ₹752.50 | +0.99% | 2.9T | 20.91 | ₹35.99 | +4.52% |
| HINDZINC.BO | ₹562.60 | -0.27% | 2.4T | 20.14 | ₹27.93 | +5.16% |
| HINDZINC.NS | ₹562.55 | -0.36% | 2.4T | 20.13 | ₹27.95 | +5.16% |
| MOIL.BO | ₹305.65 | +0.00% | 62.2B | 21.42 | ₹14.27 | +2.43% |
| MOIL.NS | ₹305.35 | -0.11% | 62.1B | 21.38 | ₹14.28 | +2.43% |
| ASHAPURMIN.BO | ₹525.90 | -0.75% | 50.2B | 13.30 | ₹39.53 | +0.19% |
| ASHAPURMIN.NS | ₹525.85 | -0.82% | 50.2B | 13.31 | ₹39.50 | +0.19% |
| ORISSAMINE.BO | ₹3,716.65 | -0.90% | 22.3B | -57.78 | -₹64.32 | N/A |
Stock Comparison
ORISSAMINE.NS vs VEDL.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, VEDL.NS has a market cap of 2.9T. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while VEDL.NS trades at ₹752.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas VEDL.NS's P/E ratio is 20.91. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to VEDL.NS's ROE of +0.31%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to VEDL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check VEDL.NS's competition here
ORISSAMINE.NS vs VEDL.BO Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, VEDL.BO has a market cap of 2.9T. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while VEDL.BO trades at ₹752.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas VEDL.BO's P/E ratio is 20.91. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to VEDL.BO's ROE of +0.31%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to VEDL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check VEDL.BO's competition here
ORISSAMINE.NS vs HINDZINC.BO Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, HINDZINC.BO has a market cap of 2.4T. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while HINDZINC.BO trades at ₹562.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas HINDZINC.BO's P/E ratio is 20.14. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to HINDZINC.BO's ROE of +0.98%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to HINDZINC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check HINDZINC.BO's competition here
ORISSAMINE.NS vs HINDZINC.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, HINDZINC.NS has a market cap of 2.4T. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while HINDZINC.NS trades at ₹562.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas HINDZINC.NS's P/E ratio is 20.13. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to HINDZINC.NS's ROE of +0.98%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to HINDZINC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check HINDZINC.NS's competition here
ORISSAMINE.NS vs MOIL.BO Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, MOIL.BO has a market cap of 62.2B. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while MOIL.BO trades at ₹305.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas MOIL.BO's P/E ratio is 21.42. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to MOIL.BO's ROE of +0.11%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to MOIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check MOIL.BO's competition here
ORISSAMINE.NS vs MOIL.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, MOIL.NS has a market cap of 62.1B. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while MOIL.NS trades at ₹305.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas MOIL.NS's P/E ratio is 21.38. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to MOIL.NS's ROE of +0.11%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to MOIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check MOIL.NS's competition here
ORISSAMINE.NS vs ASHAPURMIN.BO Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, ASHAPURMIN.BO has a market cap of 50.2B. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while ASHAPURMIN.BO trades at ₹525.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas ASHAPURMIN.BO's P/E ratio is 13.30. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to ASHAPURMIN.BO's ROE of +0.31%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to ASHAPURMIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check ASHAPURMIN.BO's competition here
ORISSAMINE.NS vs ASHAPURMIN.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, ASHAPURMIN.NS has a market cap of 50.2B. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while ASHAPURMIN.NS trades at ₹525.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas ASHAPURMIN.NS's P/E ratio is 13.31. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to ASHAPURMIN.NS's ROE of +0.31%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to ASHAPURMIN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check ASHAPURMIN.NS's competition here
ORISSAMINE.NS vs ORISSAMINE.BO Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, ORISSAMINE.BO has a market cap of 22.3B. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while ORISSAMINE.BO trades at ₹3,716.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas ORISSAMINE.BO's P/E ratio is -57.78. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to ORISSAMINE.BO's ROE of +0.64%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to ORISSAMINE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check ORISSAMINE.BO's competition here
ORISSAMINE.NS vs JGCHEM.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, JGCHEM.NS has a market cap of 13.8B. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while JGCHEM.NS trades at ₹353.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas JGCHEM.NS's P/E ratio is 21.92. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to JGCHEM.NS's ROE of +0.13%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to JGCHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check JGCHEM.NS's competition here
ORISSAMINE.NS vs SCFL.BO Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, SCFL.BO has a market cap of 5.9B. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while SCFL.BO trades at ₹26.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas SCFL.BO's P/E ratio is N/A. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to SCFL.BO's ROE of -0.05%. Regarding short-term risk, ORISSAMINE.NS is less volatile compared to SCFL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check SCFL.BO's competition here
ORISSAMINE.NS vs 20MICRONS.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, 20MICRONS.NS has a market cap of 5.7B. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while 20MICRONS.NS trades at ₹160.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas 20MICRONS.NS's P/E ratio is 8.78. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to 20MICRONS.NS's ROE of +0.15%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to 20MICRONS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check 20MICRONS.NS's competition here
ORISSAMINE.NS vs 20MICRONS.BO Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, 20MICRONS.BO has a market cap of 5.7B. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while 20MICRONS.BO trades at ₹160.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas 20MICRONS.BO's P/E ratio is 8.77. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to 20MICRONS.BO's ROE of +0.15%. Regarding short-term risk, ORISSAMINE.NS is less volatile compared to 20MICRONS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check 20MICRONS.BO's competition here
ORISSAMINE.NS vs EMAMIPAP.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, EMAMIPAP.NS has a market cap of 4.4B. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while EMAMIPAP.NS trades at ₹72.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas EMAMIPAP.NS's P/E ratio is 15.15. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to EMAMIPAP.NS's ROE of +0.05%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to EMAMIPAP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check EMAMIPAP.NS's competition here
ORISSAMINE.NS vs RAJMET.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, RAJMET.NS has a market cap of 1.1B. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while RAJMET.NS trades at ₹3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas RAJMET.NS's P/E ratio is -49.75. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to RAJMET.NS's ROE of -0.02%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to RAJMET.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check RAJMET.NS's competition here
ORISSAMINE.NS vs SICAGEN.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, SICAGEN.NS has a market cap of 973.5M. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while SICAGEN.NS trades at ₹24.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas SICAGEN.NS's P/E ratio is -164.00. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to SICAGEN.NS's ROE of +0.04%. Regarding short-term risk, ORISSAMINE.NS is less volatile compared to SICAGEN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check SICAGEN.NS's competition here
ORISSAMINE.NS vs PATSPINLTD.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, PATSPINLTD.NS has a market cap of 436M. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while PATSPINLTD.NS trades at ₹14.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas PATSPINLTD.NS's P/E ratio is -3.18. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to PATSPINLTD.NS's ROE of +0.33%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to PATSPINLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check PATSPINLTD.NS's competition here
ORISSAMINE.NS vs IMPEXFERRO.BO Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, IMPEXFERRO.BO has a market cap of 140.7M. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while IMPEXFERRO.BO trades at ₹1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas IMPEXFERRO.BO's P/E ratio is -1.93. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to IMPEXFERRO.BO's ROE of +0.02%. Regarding short-term risk, ORISSAMINE.NS is less volatile compared to IMPEXFERRO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check IMPEXFERRO.BO's competition here
ORISSAMINE.NS vs IMPEXFERRO.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, IMPEXFERRO.NS has a market cap of 138.9M. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while IMPEXFERRO.NS trades at ₹1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas IMPEXFERRO.NS's P/E ratio is -1.93. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to IMPEXFERRO.NS's ROE of +0.02%. Regarding short-term risk, ORISSAMINE.NS is less volatile compared to IMPEXFERRO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check IMPEXFERRO.NS's competition here
ORISSAMINE.NS vs ARENTERP.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, ARENTERP.NS has a market cap of 126.6M. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while ARENTERP.NS trades at ₹40.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas ARENTERP.NS's P/E ratio is -581.86. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to ARENTERP.NS's ROE of -0.00%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to ARENTERP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check ARENTERP.NS's competition here
ORISSAMINE.NS vs ARENTERP.BO Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, ARENTERP.BO has a market cap of 120.3M. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while ARENTERP.BO trades at ₹38.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas ARENTERP.BO's P/E ratio is -552.86. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to ARENTERP.BO's ROE of -0.00%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to ARENTERP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check ARENTERP.BO's competition here
ORISSAMINE.NS vs PRECISION.BO Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, PRECISION.BO has a market cap of 48.3M. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while PRECISION.BO trades at ₹54.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas PRECISION.BO's P/E ratio is -495.41. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to PRECISION.BO's ROE of +0.02%. Regarding short-term risk, ORISSAMINE.NS is less volatile compared to PRECISION.BO. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check PRECISION.BO's competition here
ORISSAMINE.NS vs METKORE.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, METKORE.NS has a market cap of 47.2M. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while METKORE.NS trades at ₹0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas METKORE.NS's P/E ratio is -0.40. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to METKORE.NS's ROE of -1.25%. Regarding short-term risk, ORISSAMINE.NS is less volatile compared to METKORE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check METKORE.NS's competition here
ORISSAMINE.NS vs ORIENTREF.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, ORIENTREF.NS has a market cap of 0. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while ORIENTREF.NS trades at ₹324.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas ORIENTREF.NS's P/E ratio is 53.11. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to ORIENTREF.NS's ROE of +0.22%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to ORIENTREF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check ORIENTREF.NS's competition here
ORISSAMINE.NS vs SEZAL.NS Comparison April 2026
ORISSAMINE.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ORISSAMINE.NS stands at 22.2B. In comparison, SEZAL.NS has a market cap of 0. Regarding current trading prices, ORISSAMINE.NS is priced at ₹3,701.20, while SEZAL.NS trades at ₹5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ORISSAMINE.NS currently has a P/E ratio of -82.97, whereas SEZAL.NS's P/E ratio is -0.00. In terms of profitability, ORISSAMINE.NS's ROE is +0.64%, compared to SEZAL.NS's ROE of +0.15%. Regarding short-term risk, ORISSAMINE.NS is more volatile compared to SEZAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for ORISSAMINE.NS.Check SEZAL.NS's competition here